Development of a prototype wound dressing technology which can detect and report colonization by pathogenic bacteria

Biosensors and Bioelectronics

Volumn 30, Issue 1, 2011, Pages 67-72

  Zhou, Jin ^a   Tun, Thet Naing ^a   Hong, Sung ha ^a   Mercer Chalmers, June D ^a   Laabei, Maisem ^a   Young, Amber E R ^b   Jenkins, A Tobias A ^a  

^a University of Bath   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

Infection; Phospholipid vesicle; Pseudomonas aeruginosa; Staphylococcus aureus; Wound dressing

Indexed keywords

INFECTION; PHOSPHOLIPID VESICLE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND-DRESSING;

BACTERIOLOGY; ESCHERICHIA COLI; LIPOSOMES; MALEIC ANHYDRIDE; PHOSPHOLIPIDS;

BACTERIA;

ALPHA HEMOLYSIN; BACTERIAL TOXIN; CARBOXYFLUORESCEIN; MALEIC ANHYDRIDE; METICILLIN; PHOSPHOLIPASE A2; TYLOXAPOL; VIRULENCE FACTOR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CONTROLLED STUDY; ESCHERICHIA COLI; LIPID VESICLE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHODOLOGY; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND DRESSING;

BACTERIAL LOAD; BANDAGES; BIOSENSING TECHNIQUES; COLORIMETRY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; PILOT PROJECTS; WOUND INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 80755140168     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2011.08.028     Document Type: Article

References (24)

1. An R.J., Friedman Y.H. J. Biomed. Mater. Res. 1998, 43:338-348.
2. Bouwstra J.A., Honeywell-Nguyen P.L. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S41-S55.
3. Branski L.K., et al. Surg. Infect. 2009, 10:389-397.
4. Byun H.-G., et al. ETRI J. 2010, 32:440-446.
5. Childs C., et al. Burns 1999, 25:473-476.
6. Falkow R.R.S., et al. Rev. Cell Biol. 1992, 8:333-363.
7. Funato K., et al. Pharm. Res. 1994, 11:372-376.
8. Gethin G. Wounds UK 2007, 13:52-56.
9. Griset A.P., et al. J. Am. Chem. Soc. 2009, 131:2469-2471.
10. Holmgren J. Nature 1981, 292:413-417.
11. Jenkins A.T.A., Young A.E.R. Expert Rev. Anti-infect. Ther. 2010, 8:1063-1065.
12. Kolusheva S., et al. Biochemistry 2000, 39:15851-15859.
13. Liu S., et al. Langmuir 2005, 21:8572-8575.
14. Lu B., et al. Drug Deliv. 2003, 10:87-94.
15. Maurer N., et al. Expert Opin. Biol. Ther. 2001, 1:1-25.
16. Meyer E., et al. Infection 2010, 38:19-24.
17. Mi F.L., et al. J. Biomed. Mater. Res. 2002, 59:438-449.
18. Poon V.K.M., Burd A. Burns 2004, 30:140-147.
19. Van Amersfoort E.S., et al. J. Clin. Microbiol. Rev. 2003, 16:379.
20. White M.C., et al. Burns 2005, 31:193-197.
21. WHO. Global Strategy for Containment of Antimicrobial Resistance, Policy Document. WHO/CDS/CSR/DRS/2001.2.
22. Yavlovich A., et al. Biochim. Biophys. Acta-Biomem. 2011, 1808:117-126.
23. Young A.E.R., Thornton K.L. Arch. Dis. Child Educ. Pract. Ed. 2007, 92:ep97-ep100.
24. Zhou J., et al. J. Am. Chem. Soc. 2010, 132:6566-6570.